The role for TGM2 in formation of the CXCL12–KRT19 coating on mouse PDA cells was assessed with s/c tumors having PDA cells in which the Tgm2 gene had been CRISPR/Cas9 edited (SI Appendix, Fig. S9). The gene discussed is CXCL12; the disease is Patent ductus arteriosus.